Journal of Liposome Research

Papers
(The TQCC of Journal of Liposome Research is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Responsiveness of glycyrrhetinic acid modified liposome toward secretory phospholipase A 2 and its growth inhibitory in Colo205 cells49
Sialic acid-modified docetaxel cationic liposomes: double targeting of tumor-associated macrophages and tumor endothelial cells40
Cheap portable electroformed giant unilamellar vesicles preparation kit31
Statement of Retraction: Retinal photoreceptors targeting SA-g-AA coated multilamellar liposomes carrier system for cytotoxicity and cellular uptake evaluation30
Dual-ligand functionalized liposomes with iRGD/trastuzumab co-loaded with gefitinib and lycorine for enhanced metastatic breast cancer therapy29
Experimental design, formulation, and in-vivo evaluation of novel anticoagulant Rivaroxaban loaded cubosomes in rats model21
Novel Hyaluronic Acid ethosomes based gel formulation for topical use with reduced toxicity, better skin permeation, deposition, and improved pharmacodynamics20
A novel nano material for anti-cerebral ischaemia: preparation and application of borneol angelica polysaccharide liposomes19
Ethosomes as dermal/transdermal drug delivery systems: applications, preparation and characterization18
Preparation of PEG-modified isoquercitrin liposomes and anti-chronic kidney disease research17
Synergistic antibacterial effect of the pistachio green hull extract-loaded porphysome decorated with 4-nitroimidazole against bacteria17
Design, optimization, and in-vivo hypoglycaemic effect of nanosized glibenclamide for inhalation delivery16
A drift on liposomes to proliposomes: recent advances and promising approaches14
Chimeric liposomes decorated with P407: an alternative biomaterial for producing stealth nano-therapeutics12
The future of lactoferrin: A closer look at LipoDuo technology11
Liposomal formulation of a vitamin C derivative: a promising strategy to increase skin permeability11
Development and evaluation of surfactant-based elastic vesicular system for transdermal delivery of Cilostazole: ex-vivo permeation and histopathological evaluation studies10
QbD-assisted development of lipidic nanocapsules for antiestrogenic activity of exemestane in breast cancer10
Multifunctional liposomal gel in regenerative medicine10
A mini review for lipid-based nanovaccines: from their design to their applications10
Eudragit S100 prepared pH-responsive liposomes-loaded betulinic acid against colorectal cancer in vitro and in vivo10
Avoiding artifacts in liposome leakage measurements via cuvette- and liposome-surface modifications9
Dyeing of polyacrylonitrile knitted fabric using liposomes8
Sialic acid-modified doxorubicin liposomes target tumor-related immune cells to relieve multiple inhibitions of CD8 + T cells8
Synthesis of liposomal nanoparticles to load 4-farnesyloxycoumarin and investigating its anti-cancer and anti-metastatic effects8
Fructose and biotin co-modified liposomes for dual-targeting breast cancer8
Permeation enhancer nanovesicles mediated topical delivery of curcumin for the treatment of hyperpigmentation7
Solid lipid nanoparticles: a versatile approach for controlled release and targeted drug delivery7
Correction7
Spanlastics nanovesicular ocular insert as a novel ocular delivery of travoprost: optimization using Box–Behnken design and in vivo evaluation6
Novel and efficient method for loading aptamer-conjugated liposomes with arsenic trioxide for targeting cancer cells6
Liposomes with cyclodextrin channels and polyethyleneimine (PEI) improves cytoplasmic vaccine delivery and induces anti-cancer immune activity in mice6
Correction6
Development and optimization of TPGS-based stealth liposome of doxorubicin using Box–Behnken design: characterization, hemocompatibility, and cytotoxicity evaluation in breast cancer cells6
A comparative study of sensitizers and liposome composition in radiation-induced controlled drug release for cancer therapy6
Development, evaluation and biodistribution of stealth liposomes of 5-fluorouracil for effective treatment of breast cancer6
0.074923038482666